Search Results 31-40 of 17160 for Reactivation tuberculosis

  1. Mayo Clinic Radio: TB / supplements and kidney disease / commercial space flight

    Tuberculosis (TB) is a potentially serious infectious disease that mainly affects the lungs. The bacteria that cause TB are spread from one person to ...

  2. A Study of Arikayce for Treatment of Mycobacteria that is not Tuberculosis - Mayo Clinic

    ... tuberculosis, and is difficult to treat. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  3. Publications - Maheen Z. Abidi, M.B.B.S., M.D. - Mayo Clinic

    ... Reactivation of Human Herpesvirus-6 in a Liver Transplant ... Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib.

  4. Discovery's Edge: First Cure With a New Drug - Mayo Clinic News Network

    Mayo Clinic's role in developing the first effective tuberculosis treatment. Patricia Thomas was trying to keep up her spirits. Her cough was not improving.

  5. Mayo Clinic Radio: Getting Enough Sleep / Tuberculosis Update / New Lyme Disease Bacterium

    Also, infectious disease specialist Dr. Stacey Rizza has an update on tuberculosis. March 24 is World TB Day. And, pathologist Dr. Bobbi Pritt has the latest on ...

  6. Pretomanid (oral route) - Side effects & dosage - Mayo Clinic

    ... tuberculosis (TB) of the lungs that is extensively drug resistant (XDR) or who cannot tolerate or do not respond to treatment for multidrug-resistant (MDR)-TB.

  7. Dr. Rozalina McCoy Archives - Mayo Clinic News Network

    Tuberculosis (TB) is a potentially serious infectious disease that mainly affects the lungs. The bacteria that cause TB are spread from one person to another ...

  8. Mayo Clinic Minute - Mayo Clinic Center for TBEDITS (1)

    One of our responsibilities is to do consultative care for health care providers in our states who have somebody with tuberculosis. Education. One of our ...

  9. Nontuberculous Mycobacterial Pulmonary Disease Clinical Trials - Mayo Clinic Research

    ... tuberculosis, and is difficult to treat. A Study of Clofazimine for Treating Patients with Drug Resistant Non-Tuberculous Mycobacterial Infections Rochester ...

  10. Publications - Tobias Peikert, M.D. - Mayo Clinic

    Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification. PLoS One. 2025; 20 (4): ...